Antares Pharma, Inc. (AIS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Join SI Premium – FREE
Antares Pharma, Inc. (NYSE: AIS) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $3.57 million versus the consensus estimate of $3.24 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
